Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents

European Journal of Medicinal Chemistry

Volumn 74, Issue , 2014, Pages 278-301

  Parra, Andres ^a   Martin Fonseca, Samuel ^a   Rivas, Francisco ^a   Reyes Zurita, Fernando J ^a   Medina O'Donnell, Marta ^a   Martinez, Antonio ^a   Garcia Granados, Andres ^a   Lupiañez, Jose A ^a   Albericio, Fernando ^b,c  

^a UNIVERSITY OF GRANADA   (Spain)

^b INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Anti HIV; Apoptosis; Green chemistry; Maslinic acid; Oleanolic acid; Triterpene

Indexed keywords

ANTINEOPLASTIC AGENT; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; HYDROXYL GROUP; MASLINIC ACID; OLEANOLIC ACID; OLIVE OIL; REACTIVE OXYGEN METABOLITE;

ACYLATION; ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG POTENCY; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IC 50; MELANOMA CELL; MOUSE; NONHUMAN; OIL INDUSTRY;

ANTI-HIV; APOPTOSIS; GREEN CHEMISTRY; MASLINIC ACID; OLEANOLIC ACID; TRITERPENE;

ACYLATION; ANTI-HIV AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; INDUSTRIAL WASTE; PLANT OILS; REACTIVE OXYGEN SPECIES; TRITERPENES;

EID: 84893183833     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2013.12.049     Document Type: Article

References (72)

1. A. Garcia-Granados, A. Martinez, J.N. Moliz, A. Parra, and F. Rivas 3β-hydroxyolean-12-en-28-oic acid (oleanolic acid) Molecules 3 1998 M87
2. A. Garcia-Granados, A. Martinez, J.N. Moliz, A. Parra, and F. Rivas 2α,3β-dihydroxyolean-12-en-28-oic acid (maslinic acid) Molecules 3 1998 M88
3. J. Pollier, and A. Goossens Oleanolic acid Phytochemistry 77 2012 10 15
4. A. Garcia-Granados, Process for the industrial recovery of oleanolic and maslinic acids contained in the olive milling byproducts, PCT. Int. Appl. WO 9804331, 1998.
5. J.M. Lou-Bonafonte, C. Arnal, M.A. Navarro, and J. Osada Efficacy of bioactive compounds from extra virgin olive oil to modulate atherosclerosis development Mol. Nutr. Food Res. 56 2012 1043 1057
6. I. Sogno, N. Vannini, G. Lorusso, R. Cammarota, D.M. Noonan, L. Generoso, M.B. Sporn, and A. Albini Anti-angiogenic activity of a novel class of chemopreventive compounds: oleanic acid terpenoids Recent Results Cancer Res. 181 2009 209 212
7. A. Petronelli, G. Pannitteri, and U. Testa Triterpenoids as new promising anticancer drugs Anti-Cancer Drugs 20 2009 880 892
8. N. Sultana, and A. Ata Oleanolic acid and related derivatives as medicinally important compounds J. Enzym. Inhib. Med. Chem. 23 2008 739 756
9. F. Mengoni, M. Lichtner, L. Battinelli, M. Marzi, C.M. Mastroianni, V. Vullo, and G. Mazzanti In vitro anti-HIV activity of oleanolic acid on infected human mononuclear cells Planta Med. 68 2002 111 114
10. M.B. Sporn, K.T. Liby, M.M. Yore, L. Fu, J.M. Lopchuk, and G.W. Gribble New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress J. Nat. Prod. 74 2011 537 545
11. K.I. Wolska, A.M. Grudniak, B. Fiecek, A. Kraczkiewicz-Dowjat, and A. Kurek Antibacterial activity of oleanolic and ursolic acids and their derivatives Cent. Eur. J. Biol. 5 2010 543 553
12. V.R. Preedy, and R.R. Watson Olives and Olive Oil in Health and Disease Prevention 2010 Elsevier London
13. R.A. Hill, and J.D. Connolly Triterpenoids Nat. Prod. Rep. 29 2012 780 818 and references therein
14. H. Sheng, and H. Sun Synthesis, biology and clinical significance of pentacyclic triterpenes: a multi-target approach to prevention and treatment of metabolic and vascular diseases Nat. Prod. Rep. 28 2011 543 593 and references therein
15. N. Sultana, and Z.S. Saify Naturally occurring and synthetic agents as potential anti-inflammatory and immunomodulants Anti-Inflamm. Anti-Allergy Agents Med. Chem. 11 2012 3 19
16. A. Bishayee, S. Ahmed, N. Brankov, and M. Perloff Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer Front. Biosci. 16 2011 980 996
17. G. Kuttan, P. Pratheeshkumar, K.A. Manu, and R. Kuttan Inhibition of tumor progression by naturally occurring terpenoids Pharm. Biol. 49 2011 995 1007
18. V.R. Yadav, S. Prasad, B. Sung, R. Kannappan, and B.B. Aggarwal Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer Toxins 2 2010 2428 2466
19. J.A.R. Salvador Pentacyclic Triterpenes as Promising Agents in Cancer 2010 Nova Science Publishers New York
20. J. Rios Effects of triterpenes on the immune system J. Ethnopharmacol. 128 2010 1 14
21. J. Feng, W. Chen, Y. Zhao, and X. Ju Anti-tumor activity of oleanolic, ursolic and glycyrrhetinic acid Open Nat. Prod. J. 2 2009 48 52
22. M.N. Laszczyk Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy Planta Med. 75 2009 1549 1560
23. P. Dzubak, M. Hajduch, D. Vydra, A. Hustova, M. Kvasnica, D. Biedermann, L. Markova, M. Urban, and J. Sarek Pharmacological activities of natural triterpenoids and their therapeutic implications Nat. Prod. Rep. 23 2006 394 411 and references therein
24. B.K. Cassels, and M. Asencio Anti-HIV activity of natural triterpenoids and hemisynthetic derivatives 2004-2009 Phytochem. Rev. 10 2011 545 564
25. C.R. Dorr, S. Yemets, O. Kolomitsyna, P. Krasutsky, and L.M. Mansky Triterpene derivatives that inhibit human immunodeficiency virus type 1 replication Bioorg. Med. Chem. Lett. 21 2011 542 545
26. R.Y. Kuo, K. Qian, S.L. Morris-Natschke, and K.H. Lee Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents Nat. Prod. Rep. 26 2009 1321 1344
27. H. Gehringer, K. Von der Helm, S. Seelmeir, B. Weissbrich, J. Eberle, and H. Nitschko Development and evaluation of a phenotypic assay monitoring resistance formation to protease inhibitors in HIV-1-infected patients J. Virol. Methods 109 2003 143 152
28. S.M. Rodems, B.D. Hamman, C. Lin, J. Zhao, S. Shah, D. Heidary, L. Makings, J.H. Stack, and B.A. Pollok A FRET-based assay platform for ultra-high density drug screening of protein kinases and phosphatases Assay Drug Dev. Technol. 1 2002 9 19
29. N.I. Ziedan, H. Kadri, and A.D. Westwell The development of pro-apoptotic cancer therapeutics Mini Rev. Med. Chem. 8 2008 711 718
30. L. Cipak, L. Grausova, E. Miadokova, L. Novotny, and P. Rauko Dual activity of triterpenoids: apoptotic versus antidifferentiation effects Arch. Toxicol. 80 2006 429 435
31. J.M.R. Patlolla, and C.V. Rao Triterpenoids for cancer prevention and treatment: current status and future prospects Curr. Pharm. Biotechnol. 13 2012 147 155
32. A. Parra, F. Rivas, S. Martin-Fonseca, A. Garcia-Granados, and A. Martinez Maslinic acid derivatives induce significant apoptosis in b16f10 murine melanoma cells Eur. J. Med. Chem. 46 2011 5991 6001
33. F.J. Reyes, J.J. Centelles, J.A. Lupiañez, and M. Cascante (2α,3β)-2,3-dihydroxyolean-12-en-28-oic acid, a new natural triterpene from Olea europaea, induces caspase dependent apoptosis selectively in colon adenocarcinoma cells FEBS Lett. 580 2006 6302 6310
34. M.E. Juan, J.M. Planas, V. Ruiz-Gutierrez, H. Daniel, and U. Wenzel Antiproliferative and apoptosis-inducing effects of maslinic and oleanolic acids, two pentacyclic triterpenes from olives, on HT-29 colon cancer cells Br. J. Nutr. 100 2008 36 43
35. R. Martin, J. Carvalho-Tavares, E. Ibeas, M. Hernandez, V. Ruiz-Gutierrez, and M.L. Nieto Acidic triterpenes compromise growth and survival of astrocytoma cell lines by regulating reactive oxygen species accumulation Cancer Res. 67 2007 3741 3751
36. F.J. Reyes-Zurita, E.E. Rufino-Palomares, J.A. Lupiañez, and M. Cascante Maslinic acid, a natural triterpene from Olea europaea L., induces apoptosis in HT29 human colon-cancer cells via the mitochondrial apoptotic pathway Cancer Lett. 273 2009 44 54
37. F.J. Reyes-Zurita, G. Pachon-Pena, D. Lizarraga, E.E. Rufino-Palomares, M. Cascante, and J.A. Lupiañez The natural triterpene maslinic acid induces apoptosis in HT29 colon cancer cells by a JNK-p53-dependent mechanism BMC Cancer 11 2011 154
38. E.E. Rufino-Palomares, F.J. Reyes-Zurita, L. Garcia-Salguero, K. Mokhtari, P.P. Medina, J.A. Lupiañez, and J. Peragon Maslinic acid, a triterpenic anti-tumoural agent, interferes with cytoskeleton protein expression in HT29 human colon-cancer cells J. Proteomics 83 2013 15 25
39. S. Sanchez-Tena, F.J. Reyes-Zurita, S. Diaz-Moralli, M.P. Vinardell, M. Reed, F. Garcia-Garcia, J. Dopazo, J.A. Lupiañez, U. Günther, and M. Cascante Maslinic acid-enriched diet decreases intestinal tumorigenesis in ApcMin/+ mice through transcriptomic and metabolomic reprogramming PLoS One 8 2013 e59392
40. Y.K. Kim, S.K. Yoon, and S.Y. Ryu Cytotoxic triterpenes from stem bark of Physocarpus intermedius Planta Med. 66 2000 485 486
41. X. Wang The expanding role of mitochondria in apoptosis Genes Dev. 15 2001 2922 2933
42. S.Y. Sun, N. Hail Jr., and R. Lotan Apoptosis as a novel target for cancer chemoprevention J. Natl. Cancer Inst. 96 2004 662 672
43. O. Micheau, and J. Tschopp Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes Cell 114 2003 181 190
44. A. Ashkenazi Targeting the extrinsic apoptosis pathway in cancer Cytokine Growth Factor Rev. 19 2008 325 331
45. S.T. Derek Diversity-oriented synthesis: exploring the intersections between chemistry and biology Nat. Chem. Biol. 1 2005 74 84
46. D.J. Newman, and G.M. Cragg Natural products as sources of new drugs over the 30 years from 1981 to 2010 J. Nat. Prod. 75 2012 311 335
47. A. Ganesan The impact of natural products upon modern drug discovery Curr. Opin. Chem. Biol. 12 2008 306 317
48. M.E. Welsch, S.A. Snyder, and B.R. Stockwell Privileged scaffolds for library design and drug discovery Curr. Opin. Chem. Biol. 14 2010 347 361
49. V.L. Eifer-Lima, C.S. Graebin, F.D.T. Uchoa, P.D. Duarte, and A.G. Corrêa Highlights in the solid-phase organic synthesis of natural products and analogues J. Braz. Chem. Soc. 21 2010 1401 1423
50. T. Kodadek The rise, fall and reinvention of combinatorial chemistry Chem. Commun. 47 2011 9757 9763
51. A. Ganesan Natural products as a hunting ground for combinatorial chemistry Curr. Opin. Biotechnol. 15 2004 584 590
52. P.E. Lopez, A. Isidro-Llobet, C. Gracia, L.J. Cruz, A. Garcia-Granados, A. Parra, and M. Alvarez Use of p-nitrobenzyloxycarbonyl (pNZ) as a permanent protecting group in the synthesis of Kahalalide F analogs Tetrahedron Lett. 46 2005 7737 7741
53. A. Parra, F. Rivas, P.E. Lopez, A. Garcia-Granados, A. Martinez, F. Albericio, and N. Marquez Solution- and solid-phase synthesis and anti-HIV activity of maslinic acid derivatives containing amino acids and peptides Bioorg. Med. Chem. 17 2009 1139 1145
54. S. Wang, and W. Fang Design and synthesis of a dual linker for solid phase synthesis of oleanolic acid derivatives Molecules 16 2011 4748 4763
55. R. Weis, and W. Seebacher Complete assignment of 1H and 13C NMR spectra of new pentacyclic triterpene acid benzyl esters Magn. Reson. Chem. 40 2002 455 457
56. A. Garcia-Granados, J. Dueñas, J.N. Moliz, A. Parra, F.L. Perez, J.A. Dobado, and J. Molina Semi-synthesis of triterpene A-ring derivatives from oleanolic and maslinic acids. Theoretical and experimental 13C chemical shifts J. Chem. Res. (M) 2000 326 339
57. A. Garcia-Granados, J. Dueñas, E. Melguizo, J.N. Moliz, A. Parra, F.L. Perez, J.A. Dobado, and J. Molina Semi-synthesis of triterpene A-ring derivatives from oleanolic and maslinic acids. Part II. Theoretical and experimental 13C chemical shifts J. Chem. Res. (M) 2000 653 670
58. J. Hao, J. Liu, X. Wen, and H. Sun Synthesis and cytotoxicity evaluation of oleanolic acid derivatives Bioorg. Med. Chem. Lett. 23 2013 2074 2077
59. F.B.H. Ahmad, M.G. Moghaddam, M. Basri, and M.B. Abdul Rahman Anticancer activity of 3-O-acylated betulinic acid derivatives obtained by enzymatic synthesis Biosci. Biotechnol. Biochem. 74 2010 1025 1029
60. M.K. Shanmugam, A.H. Nguyen, A.P. Kumar, B.K.H. Tan, and G. Sethi Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: potential role in prevention and therapy of cancer Cancer Lett. 320 2012 158 170
61. Y. Qurishi, A. Hamid, P.R. Sharma, Z.A. Wani, D.M. Mondhe, S.K. Singh, M.A. Zargar, S.S. Andotra, B.A. Shah, S.C. Taneja, and A.K. Saxena PARP cleavage and perturbance in mitochondrial membrane potential by 3-α-propionyloxy- β-boswellic acid results in cancer cell death and tumor regression in murine models Future Oncol. 8 2012 867 881
62. I. Murtaza, M. Saleem, V.M. Adhami, B.B. Hafeez, and H. Mukhtar Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells Cancer Res. 69 2009 1156 1165
63. J. Wei, M. Liu, H. Liu, H. Wang, F. Wang, Y. Zhang, L. Hana, and X. Lina Oleanolic acid arrests cell cycle and induces apoptosis via ROS-mediated mitochondrial depolarization and lysosomal membrane permeabilization in human pancreatic cancer cells J. Appl. Toxicol. 33 2013 756 765
64. R.K. Emaus, R. Grunwald, and J.J. Lemasters Rhodamine 123 as a probe of transmembrane potential in isolated rat-liver mitochondria: spectral and metabolic properties Biochim. Biophys. Acta 850 1986 436 448
65. H. Li, H. Zhu, C.J. Xu, and J. Yuan Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis Cell 94 1998 491 501
66. X. Luo, I. Budihardjo, H. Zou, C. Slaughter, and X. Wang Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors Cell 94 1998 481 490
67. L. Huang, and C.H. Chen The molecular targets of anti-HIV-1 triterpenes, an update Med. Chem. Rev. Online 2 2005 423 427
68. K. Qian, R.Y. Kuo, C.H. Chen, L. Huang, S.L. Morris-Natschke, and K.H. Lee Anti-AIDS agents 81. Design, synthesis, and structure-activity relationship study of betulinic acid and moronic acid derivatives as potent HIV maturation inhibitors J. Med. Chem. 53 2010 3133 3141
69. Y.M. Zhu, J.K. Shen, H.K. Wang, L.M. Cosentino, and K.H. Lee Synthesis and anti-HIV activity of oleanolic acid derivatives Bioorg. Med. Chem. Lett. 11 2001 3115 3118
70. K. Qian, K. Nakagawa-Goto, D. Yu, S.L. Morris-Natschke, T.J. Nitz, N. Kilgore, G.P. Allaway, and K.H. Lee Anti-AIDS agents 73: structure-activity relationship study and asymmetric synthesis of 3-O-monomethylsuccinyl-betulinic acid derivatives Bioorg. Med. Chem. Lett. 17 2007 6553 6557
71. K. Qian, D. Yu, C.H. Chen, L. Huang, S.L. Morris-Natschke, T.J. Nitz, K. Salzwedel, M. Reddick, G.P. Allaway, and K.H. Lee Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents J. Med. Chem. 52 2009 3248 3258
72. A. Martinez, F. Rivas, A. Perojil, A. Parra, A. Garcia-Granados, and A. Fernandez-Vivas Biotransformation of oleanolic and maslinic acids by Rhizomucor miehei Phytochemistry 94 2013 229 237